SFDA To Establish Early Warning System For Drugs
This article was originally published in PharmAsia News
China State FDA will establish an early warning system as well as adopt coordinated steps to prevent or minimize harm to the public from adverse drug effects. Since setting up a notification procedure in 2001, the health care community and patients have been informed of 49 drugs with potential issues. SFDA will, according to the degree of risk, undertake five measures to supervise drugs with reported adverse reactions: (1) order drug producers to modify the product package inserts; (2) suspend the affected drugs' sale and use; (3) get drug manufacturers to improve production techniques; (4) convert OTC to prescription drugs; and (5) demand the drugs to be withdrawn from the market. (Click here for more - Chinese Language)
You may also be interested in...
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.